Joan Herman - Convergys Independent Director
Director
Ms. Joan Elizabeth Herman is an Independent Director of the Company. She is President and CEO, Herman Associates LLC, a health care and management consulting firm, 1998 2008 Various senior management positions with Anthem, Inc., a leading managed health care company, most recently serving as President and CEO, Consumer Business Unit. chosen to serve based upon her leadership experience and judgment, prior and current experience as President and CEO, international business experience, health care and insurance industry knowledge, as well as her diversity of viewpoint and experience. since 2011.
Age | 63 |
Tenure | 13 years |
Phone | 513 723-7000 |
Web | www.convergys.com |
Convergys Management Efficiency
The company has Return on Asset of 4.71 % which means that on every $100 spent on assets, it made $4.71 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 8.28 %, implying that it generated $8.28 on every 100 dollars invested. Convergys' management efficiency ratios could be used to measure how well Convergys manages its routine affairs as well as how well it operates its assets and liabilities.The company has 119.9 M in debt with debt to equity (D/E) ratio of 8.8, demonstrating that the company may be unable to create cash to meet all of its financial commitments. Convergys has a current ratio of 2.18, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Convergys until it has trouble settling it off, either with new capital or with free cash flow. So, Convergys' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Convergys sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Convergys to invest in growth at high rates of return. When we think about Convergys' use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | DIRECTOR Age | ||
Jeffrey Jones | Visteon Corp | 66 | |
Joseph Carleone | Sensient Technologies | 75 | |
Franklin Feder | PACCAR Inc | 66 | |
Suresh Garimella | Modine Manufacturing | 56 | |
Hank Brown | Sensient Technologies | 78 | |
Donald Landry | Sensient Technologies | 66 | |
James Barrese | Visteon Corp | 50 | |
Bradley Buss | Tesla Inc | 54 | |
Thomas Stafford | NL Industries | 90 | |
Joshua Bekenstein | BRP Inc | 59 | |
Louis Laporte | BRP Inc | 56 | |
Heidi Sepanik | Visteon Corp | N/A | |
Larry Ellison | Tesla Inc | N/A | |
Ernest Nicolas | Avient Corp | 43 | |
Elaine Wedral | Sensient Technologies | 77 | |
Kathleen WilsonThompson | Tesla Inc | 60 | |
David Bills | Modine Manufacturing | 59 | |
Eric Ashleman | Modine Manufacturing | 54 | |
Joseph Robbins | BRP Inc | 37 | |
Harry Wilson | Visteon Corp | 46 | |
Ira Ehrenpreis | Tesla Inc | 49 |
Management Performance
Return On Equity | 8.28 | |||
Return On Asset | 4.71 |
Convergys Leadership Team
Elected by the shareholders, the Convergys' board of directors comprises two types of representatives: Convergys inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Convergys. The board's role is to monitor Convergys' management team and ensure that shareholders' interests are well served. Convergys' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Convergys' outside directors are responsible for providing unbiased perspectives on the board's policies.
Thomas Monahan, Independent Director | ||
Jarrod Pontius, Chief Administrative Officer, General Counsel | ||
Joseph Gibbs, Independent Director | ||
Maria Klyuev, Director, Investor Relations & Marketing | ||
Bo Wang, Independent Non-Executive Director | ||
Marjorie Connelly, COO | ||
Siu Chan, Independent Non-Executive Director | ||
Hua Lu, Executive Director | ||
David Stein, IR Contact Officer | ||
Jeffrey Fox, Non-Executive Chairman of the Board | ||
Michael Wagman, President Managing Director, Director | ||
Richard Devenuti, Independent Director | ||
Isadore Sharp, Independent Director | ||
Ronald Nelson, Lead Independent Director | ||
Joseph Rotman, Independent Director | ||
Richard Wallman, Independent Director | ||
Cormac Twomey, Chief Commercial Officer | ||
John Krediet, Independent Director | ||
Joan Herman, Independent Director | ||
Cheryl Beebe, Director | ||
Gerald Heffernan, Independent Director | ||
Qingxi Wang, Executive Director | ||
Ka Lee, Company Secretary, Non-Executive Director | ||
Andrea Ayers, CEO and President Director and Member of Executive Committee | ||
Weidong Pan, Executive Vice Chairman of the Board | ||
Kin Chak, Executive Director | ||
Andre Valentine, CFO | ||
Huaiyu Wang, Executive Director | ||
Kenneth Rotman, CEO, Managing Director | ||
Jinming Yu, Independent Non-Executive Director | ||
Kathy Juve, Senior Vice President - Global Marketing and Product Development | ||
Chunlei Li, Executive Director | ||
Cuilong Zhang, Executive Director | ||
James Miller, General Counsel, Secretary | ||
John Barrett, Independent Director | ||
Robert Knowling, Director | ||
Chuan Chen, Independent Non-Executive Director | ||
Daniel Cheng, CFO | ||
Joseph Heffernan, Independent Chairman of the Board | ||
John Barnett, Independent Director | ||
Yuk Lo, Independent Non-Executive Director | ||
Michael Bregman, Independent Director | ||
Lionel Schipper, Independent Director | ||
Dongchen Cai, Executive Chairman of the Board, CEO | ||
Jeffrey Parr, Vice Chairman of the Board, Managing Director | ||
Zhenguo Wang, Executive Director |
Convergys Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Convergys a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 8.28 | |||
Return On Asset | 4.71 | |||
Profit Margin | 4.14 % | |||
Operating Margin | 12.17 % | |||
Current Valuation | 2.25 B | |||
Shares Outstanding | 91.16 M | |||
Shares Owned By Insiders | 84.99 % | |||
Shares Owned By Institutions | 0.06 % | |||
Number Of Shares Shorted | 6.48 M | |||
Price To Earning | 19.39 X |
Pair Trading with Convergys
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Convergys position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Convergys will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to CSX could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CSX when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CSX - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CSX Corporation to buy it.
The correlation of CSX is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CSX moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CSX Corporation moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CSX can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Convergys Stock
If you are still planning to invest in Convergys check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Convergys' history and understand the potential risks before investing.
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |